Amyloid-β Peptides Interact with Plasma Proteins and Erythrocytes: Implications for Their Quantitation in Plasma

Kuo, Yu-Min, Kokjohn, Tyler A., Kalback, Walter, Luehrs, Dean, Galasko, Douglas R., Chevallier, Nathalie, Koo, Edward H., Emmerling, Mark R. +1 more·2000·Biochemical and Biophysical Research Communications
DOI 10.1006/bbrc.2000.2222

Cited by (230)

Items 201–230 of 230

  1. Molecular dynamics of amyloid-β transport in Alzheimer's disease: Exploring therapeutic plasma exchange with albumin replacement – Current insights and future perspectives
    R. Mondal, Shramana Deb, Gourav Shome, Vramanti Sarkar, Durjoy Lahiri, S.S. Datta, Julián Benito‐León · 2025 · Neurología (English Edition)
  2. Generation of Rabbit Monoclonal Antibody to Amyloid-β 38 (Aβ 38 ): Increased Plasma Aβ 38 Levels in Down Syndrome
    Pankaj D Mehta, Bruce A. Patrick, Marc Barshatzky, Sangita P. Mehta, Janusz Frackowiak, Bozena Mazur‐Kolecka, David L. Miller · 2015 · Journal of Alzheimer s Disease
  3. Peripheral Fluid-Based Biomarkers of Alzheimer’s Disease
    Tapan K. Khan · 2016 · Elsevier eBooks
  4. Methionine 35 sulphoxide reduces toxicity of Aβ in red blood cell
    Cristiana Carelli‐Alinovi, Francesco Misiti · 2017 · European Journal of Clinical Investigation
  5. The diagnostic value of plasma Aβ42 and Aβ40 in Alzheimer’s disease: current status, challenges, and impacting variables
    Xiuzhi Duan, Fengyi Wang, Weiwei Liu, Yiyi Xie, Meng Yang, Ying Ping, Yu Pan, Zhenli Wei, Hongxin Li, Qiu-Ping Zhang et al. · 2025 · Journal of Neurology
  6. Interaction of C-terminal Truncated Beta-amyloid Peptides with Human Serum Albumin
    Diba Aslani Firozabadi, Mohammad Reza Bozorgmehr, S. Ali Beyramabadi, Sharareh Mohseni · 2023 · Current Proteomics
  7. Development and validation of a nomogram for predicting the risk of cognitive impairment among chronic obstructive pulmonary diseases
    Ying Fan, Chao Zhang, Zhixin Fan, Zheshu Xie, Qiuhua Sun · 2025 · Annals of Medicine
  8. Aluminum increases toxic effects of amyloid β-peptides on the human erythrocyte membrane and molecular models
    Mario Suwalsky, Pedro Hernández, Carlos Patricio Sotomayor · 2012 · Springer eBooks
  9. Alzheimer’s Diseases: Towards Biomarkers for an Early Diagnosis
    Benaïssa Elmoualij, Ingrid Dupiereux-Fettweis, Jérémie Seguin, Isabelle Quadrio, Willy Zorzi, Armand Perret‐Liaudet, Ernst Heine · 2011 · InTech eBooks
  10. Circulating Amyloid-β and Methionine-Related Metabolites to Predict the Risk of Mild Cognitive Impairment: A Nested Case-Control Study
    Jingzhu Fu, Yun Zhu, Yue Sun, Qian Liu, Huilian Duan, Ling Huang, Dezheng Zhou, Zehao Wang, Jing Zhao, Zhenshu Li et al. · 2022 · Journal of Alzheimer s Disease
  11. Impact of therapeutic and low volume plasma exchange on clinical laboratory parameters in patients treated for Alzheimer's disease from the AMBAR study
    Carlota Grifols, Miquel Barceló, Laura Núñez, Zbigniew M. Szczepiorkowski, Merçé Boada, Oscar L. López, Antonio Páez · 2023 · Therapeutic Apheresis and Dialysis
  12. A method to prevent cross contamination during 2‐DE by β‐amyloid peptides
    Heinke Schieb, Philipp Spitzer, Verena Riess, Jens Wiltfang, Hans‐Wolfgang Klafki · 2010 · PROTEOMICS
  13. Chlorogenic Acid Enhances the Chaperone Potential of BSA at Physiological Concentrations on Model Protein Cytochrome c
    Sadaf Sultan Khan, Neha Kausar Ansari, Aabgeena Naeem · 2024 · Cell Biochemistry and Biophysics
  14. Ultrasensitive Assay Technologies
    Charles Shieh-Yueh Yang, Marwan Noel Sabbagh · 2026 · Springer eBooks
  15. Virtual Screening of Human Serum Albumin Mutants to Optimize the Search for its Forms that Increase Affinity to Amyloid-Β Peptide
    Evgenia I. Deryusheva, Мачулин Андрей Валериевич, Литус Екатерина Андреевна · 2023 · BIO Web of Conferences
  16. The role of human serum albumin in prevention and treatment of Alzheimer’s disease
    Marina P. Shevelyova, Evgenia I. Deryusheva, Немашкалова Екатерина Леонидовна, Мачулин Андрей Валериевич, Литус Екатерина Андреевна · 2023 · Журнал общей биологии
  17. Die Amyloidablagerung in einem Mausmodell der Alzheimer Demenz und die Modulation der β-Amyloid-Peptidentstehung durch membranverankerte Inhibitoren
    Heinke Schieb · 2011 · DuEPublico (University of Duisburg-Essen)
  18. GENOME-WIDE ASSOCIATION STUDIES AT THE INTERFACE OF ALZHEIMER'S DISEASE AND EPIDEMIOLOGICALLY RELATED DISORDERS
    Christopher R Simmons · 2011 · UKnowledge (University of Kentucky)
  19. Role of the 39-kDa receptor-associated protein (RAP) in Alzheimer's disease
    Hoang, T · 2012 · UTAS Research Repository
  20. Relevance of quantitative measurements of anti-Aβ antibodies in therapeutic intravenous immunoglobulin using synthetic peptides
    Juan Ignacio Jorquera · 2009 · International Immunopharmacology
  21. How Close are We to a Readily available, Clinically Reliable Blood Test for Alzheimer's disease?
    Pedro Pesini, Manuel Sarasa · 2013 · Neurodegenerative Disease Management
  22. ALTERATIONS IN HUMAN RED BLOOD CELL MEMBRANE PROPERTIES IN ALZHEIMER DISEASE PATIENTS
    Róbert Hajduk · 2010
  23. A Novel Mechanism Underlies Pathological, β-amyloid-induced Neuronal Hyperexcitation
    Qiang Liu · 2011
  24. Systemic Amyloid-β Metabolism in Alzheimer’s Disease
    Fan Dong-yu, Jun Wang, Ben J. Gu, Colin Louis Masters, Yan‐Jiang Wang · 2026 · Springer eBooks
  25. Brain‐peripheral proteome crosstalk in Alzheimer's disease with and without diabetes mellitus
    Anat Yaskolka Meir, Xingyan Wang, Shinya Tasaki, Vishal Sarsani, Aron S. Buchman, Steven Edward Arnold, David A. A Bennett, Vladislav Petyuk, Liming Liang, Ana Werneck Capuano et al. · 2026 · Alzheimer s & Dementia
  26. A high-throughput conditioned-media-based screening system identifies inhibitors of aggregation induced by iPSC-secreted amyloid β
    Masahiro Kuragano, Naoki Nishishita, Koki Araya, Akira Kobayashi, Taro Q. P. Noguchi, Kenichi Watanabe, Shinya Watanabe, Stefan Baar, Koji Uwai, Kiyotaka Tokuraku · 2026 · Nature Communications
  27. Exploration de nouveaux biomarqueurs plasmatiques pour le diagnostic de la maladie d’Alzheimer
    Emilie Rossi · 2021
  28. Therapeutic plasma exchange in Alzheimer’s disease: From clinical trial to real-world evidence
    Bhupendra O. Khatri · 2026 · Transfusion and Apheresis Science
  29. New insight into Alzheimer’s disease: small molecule-Aβ in the brain transport and peripheral organ clearance
    Ma Tianci, Li Yongyi, Yuting Ding, Shijie Liu, Chuanhao Gao, Xiang Li, Zhiqian Tong, Lv Yan · 2026 · Frontiers in Aging
  30. The chemical oxidation of albumin affects its capability to bind amyloid beta 1–40 peptide and to inhibit its aggregation
    Maria Luisa Perina, Damiano Calcagno, Diego Sbardella, Davide Deodato, Alessia Distefano, Nunzio Tuccitto, Valentina Oliveri, Florence Schlotter, Peter Faller, Giuseppe Grasso · 2026 · International Journal of Biological Macromolecules